tocilizumabprednisoneTNF-iSarcopeniarheumatoid arthritisRA
…or inhibitors (TNF-i) use (OR 0.502, 95% CI 0.312 to 0.808) and tocilizumab use (OR 0.493, 95% CI 0.304 to 0.799) were associated with sarc…
1articles mentioning drugs
2drug mentions
1distinct drugs extracted
0%of mentions human-reviewed
Active filtersEntity: TNF-i ×
TNF-i
This drug is selected. Its supporting articles are shown below.